Enhancing Triple Negative Breast Cancer Immunotherapy by ICG‐Templated Self‐Assembly of Paclitaxel Nanoparticles
出版年份 2019 全文链接
标题
Enhancing Triple Negative Breast Cancer Immunotherapy by ICG‐Templated Self‐Assembly of Paclitaxel Nanoparticles
作者
关键词
-
出版物
ADVANCED FUNCTIONAL MATERIALS
Volume -, Issue -, Pages 1906605
出版商
Wiley
发表日期
2019-11-09
DOI
10.1002/adfm.201906605
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy
- (2019) Qian Chen et al. ADVANCED MATERIALS
- Antigens reversibly conjugated to a polymeric glyco-adjuvant induce protective humoral and cellular immunity
- (2019) D. Scott Wilson et al. NATURE MATERIALS
- Delivery technologies for cancer immunotherapy
- (2019) Rachel S. Riley et al. NATURE REVIEWS DRUG DISCOVERY
- Emerging Nano-/Microapproaches for Cancer Immunotherapy
- (2019) Yu Mi et al. Advanced Science
- Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer
- (2019) D. Merino et al. Nature Communications
- Development of “CLAN” Nanomedicine for Nucleic Acid Therapeutics
- (2019) Cong‐Fei Xu et al. Small
- Bioengineered Nanocage from HBc Protein for Combination Cancer Immunotherapy
- (2019) Wenjun Shan et al. NANO LETTERS
- Self-Assembling Endogenous Biliverdin as a Versatile Near-Infrared Photothermal Nanoagent for Cancer Theranostics
- (2019) Ruirui Xing et al. ADVANCED MATERIALS
- Tumor Microenvironment-Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade
- (2019) Fangyuan Zhou et al. ADVANCED MATERIALS
- In Situ Dendritic Cell Vaccine for Effective Cancer Immunotherapy
- (2019) Weijing Yang et al. ACS Nano
- Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
- (2019) Leonie Voorwerk et al. NATURE MEDICINE
- Immune-checkpoint inhibition for metastatic triple-negative breast cancer: safety first?
- (2019) Nina D’Abreo et al. Nature Reviews Clinical Oncology
- Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy
- (2019) Chrétien et al. Cancers
- Adding Nanotechnology to the Metastasis Treatment Arsenal
- (2019) Debarshi Banerjee et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Engineering nanoparticles to locally activate T cells in the tumor microenvironment
- (2019) Dangge Wang et al. Science Immunology
- Self‐Amplified Drug Delivery with Light‐Inducible Nanocargoes to Enhance Cancer Immunotherapy
- (2019) Bing Feng et al. ADVANCED MATERIALS
- Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells
- (2018) Yaqi Lv et al. ACS Nano
- Enhanced Immunotherapy Based on Photodynamic Therapy for Both Primary and Lung Metastasis Tumor Eradication
- (2018) Wen Song et al. ACS Nano
- Bioinspired Hybrid Protein Oxygen Nanocarrier Amplified Photodynamic Therapy for Eliciting Anti-tumor Immunity and Abscopal Effect
- (2018) Zhikuan Chen et al. ACS Nano
- Injectable Bioresponsive Gel Depot for Enhanced Immune Checkpoint Blockade
- (2018) Shuangjiang Yu et al. ADVANCED MATERIALS
- Nanoparticle-mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy
- (2018) Xiaopin Duan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Smart Nanoreactors for pH-Responsive Tumor Homing, Mitochondria-Targeting, and Enhanced Photodynamic-Immunotherapy of Cancer
- (2018) Guangbao Yang et al. NANO LETTERS
- Chemotherapy induces enrichment of CD47+/CD73+/PDL1+immune evasive triple-negative breast cancer cells
- (2018) Debangshu Samanta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- In situ formed reactive oxygen species–responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy
- (2018) Chao Wang et al. Science Translational Medicine
- Defining and Understanding Adaptive Resistance in Cancer Immunotherapy
- (2018) Tae Kon Kim et al. TRENDS IN IMMUNOLOGY
- Elimination of established tumors with nanodisc-based combination chemoimmunotherapy
- (2018) Rui Kuai et al. Science Advances
- Stromal Modulation Reverses Primary Resistance to Immune Checkpoint Blockade in Pancreatic Cancer
- (2018) Jun Zhao et al. ACS Nano
- Binary Cooperative Prodrug Nanoparticles Improve Immunotherapy by Synergistically Modulating Immune Tumor Microenvironment
- (2018) Bing Feng et al. ADVANCED MATERIALS
- Biomedical applications of mRNA nanomedicine
- (2018) Qingqing Xiong et al. Nano Research
- Translational control of tumor immune escape via the eIF4F–STAT1–PD-L1 axis in melanoma
- (2018) Michaël Cerezo et al. NATURE MEDICINE
- In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
- (2018) Qian Chen et al. Nature Nanotechnology
- Cancer immunoediting and resistance to T cell-based immunotherapy
- (2018) Jake S. O’Donnell et al. Nature Reviews Clinical Oncology
- Immunotherapy of cancers comes of age
- (2017) Hila Yousefi et al. Expert Review of Clinical Immunology
- PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: updated survival data
- (2017) Pedro N Aguiar et al. Immunotherapy
- Albumin-coated nanocrystals for carrier-free delivery of paclitaxel
- (2017) Joonyoung Park et al. JOURNAL OF CONTROLLED RELEASE
- Biological Photothermal Nanodots Based on Self-Assembly of Peptide–Porphyrin Conjugates for Antitumor Therapy
- (2017) Qianli Zou et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy
- (2017) Yuanzeng Min et al. Nature Nanotechnology
- Male occult triple-negative breast cancer with dermatomyositis: a case report and review of the literature
- (2017) Le Zhang et al. OncoTargets and Therapy
- Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
- (2017) Angel Garcia-Diaz et al. Cell Reports
- Phospholipid-mimic oxaliplatin prodrug liposome for treatment of the metastatic triple negative breast cancer
- (2017) Bing Feng et al. Biomaterials Science
- Carrier-Free, Chemophotodynamic Dual Nanodrugs via Self-Assembly for Synergistic Antitumor Therapy
- (2016) Ruiyun Zhang et al. ACS Applied Materials & Interfaces
- Simple Peptide-Tuned Self-Assembly of Photosensitizers towards Anticancer Photodynamic Therapy
- (2016) Kai Liu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
- (2016) Kei Muro et al. LANCET ONCOLOGY
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity
- (2016) R. D. Dorand et al. SCIENCE
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Pharmacologic Sensitivity of Paclitaxel to Its Delivery Vehicles Drives Distinct Clinical Outcomes of Paclitaxel Formulations
- (2015) Yan Li et al. MOLECULAR PHARMACEUTICS
- Near infrared light-actuated gold nanorods with cisplatin–polypeptide wrapping for targeted therapy of triple negative breast cancer
- (2015) Bing Feng et al. Nanoscale
- IDO inhibitors move center stage in immuno-oncology
- (2015) Cormac Sheridan NATURE BIOTECHNOLOGY
- CD47 blockade triggers T cell–mediated destruction of immunogenic tumors
- (2015) Xiaojuan Liu et al. NATURE MEDICINE
- Combination cancer immunotherapies tailored to the tumour microenvironment
- (2015) Mark J. Smyth et al. Nature Reviews Clinical Oncology
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- A paclitaxel-loaded recombinant polypeptide nanoparticle outperforms Abraxane in multiple murine cancer models
- (2015) Jayanta Bhattacharyya et al. Nature Communications
- Self-assembled micellar nanocomplexes comprising green tea catechin derivatives and protein drugs for cancer therapy
- (2014) Joo Eun Chung et al. Nature Nanotechnology
- Triple-negative breast cancer: disease entity or title of convenience?
- (2010) Lisa Carey et al. Nature Reviews Clinical Oncology
- Paclitaxel and immune system
- (2009) Aqeel Javeed et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
- (2009) François Ghiringhelli et al. NATURE MEDICINE
- Second malignancies after breast cancer: the impact of different treatment modalities
- (2008) Y M Kirova et al. BRITISH JOURNAL OF CANCER
- Differential impairment of regulatory T cells rather than effector T cells by paclitaxel-based chemotherapy
- (2008) Lei Zhang et al. CLINICAL IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started